Antagonism of u46619-induced aggregation of human and canine platelets by four txa2 receptor antagonists

This publication has 23 references indexed in Scilit:

• AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.
  Circulation, 1985
• The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug
  Thrombosis Research, 1984
• BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN
  The Lancet, 1984
• Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets
  Thrombosis Research, 1984
• Studies on RX 781094: a selective, potent and specific antagonist of α₂‐adrenoceptors
  British Journal of Pharmacology, 1983
• COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H₂‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H₂ AND THROMBOXANE A₂ ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONS
  British Journal of Pharmacology, 1981
• Platelets and the vascular responses to arachidonic acid in dogs
  Cardiovascular Research, 1977
• Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acid
  European Journal of Pharmacology, 1976
• The synthesis of prostaglandin endoperoxide analogs
  Tetrahedron Letters, 1975
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
  Nature, 1962